Tag: Cancer: Misc.
HPV Vaccination After Lesion Treatment Is Likely Cost-Effective
Adjuvant HPV vaccination could reduce anal cancer risk in HIV-infected men who have sex with men
Negative Margins, Lymph Node Yields Predict Survival
Can be used as metrics for hospitals performing head and neck squamous cell carcinoma surgery
Most Cancer Drugs Approved in Europe Show No Survival Benefit
Even in the postmarketing period, half of cancers have no evidence of significant survival gain
Smoking Cessation Support Less Likely for Cancer Patients
General practitioners less likely to support smoking cessation in patients with cancer than with CHD
Rate of Obesity-, Overweight-Related Cancers High in the U.S.
40 percent of cancer diagnoses tied to extra weight; rate higher in older individuals, females
Sodium-Glucose Cotransporter 2 Inhibitors Not Cancer Risk Factor
Overall cancer risk not increased compared with placebo, other active glucose-lowering treatments
Legal Cannabis Use Common Among Cancer Patients
Legalization increases likelihood of use; most want information about the drug from their doctors
Hypermutated ctDNA Linked to Checkpoint Inhibitor Response
Patients with high alteration number in variants of unknown significance had better outcomes
September 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2017. This roundup includes...
Immune Checkpoint Inhibitor Endocrine Dysfunction Explored
Patients on combination therapy have increased risk of thyroid dysfunction and hypophysitis
